![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » DiaSorin Molecular’s Herpes Assay Grabs CE Mark
DiaSorin Molecular’s Herpes Assay Grabs CE Mark
![](https://www.fdanews.com/ext/resources/test/Device_Images6/DiaSorinMolecular_Logo.png?t=1558130256&width=430)
May 17, 2019
DiaSorin Molecular earned the CE Mark for its Simplexa HSV 1/2 and VZV Universal Direct MDx assay, a diagnostic for the herpes simplex and varicella-zoster viruses.
The assay is designed for use on the devicemaker’s Liaison MDx instrument. It can detect and differentiate between DNA associated with herpes 1 and 2 and the varicella-zoster virus, which causes shingles and chickenpox.
The real-time PCR assay does not require upfront extraction, produces results in about an hour and involves minimal hands-on interaction.
Upcoming Events
-
21Oct